Collection of urine samples from infants is sometimes desired for medical diagnostic or research purposes, for example, to identify or study characteristics or effects of medical conditions such as infections, allergies, presence of drugs in the infants' systems, or other conditions. Urine can be tested to yield information relating to kidney function, electrolyte balance and some illnesses and infections. Testing for the presence of drugs in newborn babies is increasingly desired, as problems associated with maternal drug abuse are coming under greater scrutiny; analysis of urine samples is a commonly used testing method.
Typically in such circumstances it is desired to obtain a sample that is free of contamination by fecal matter or other substances that may contact the urine after urination. It is also typically desired that the urine sample is intact, in that quantities or water or other constituents have not been removed by, e.g., evaporation or absorption into, e.g., absorbent components of a diaper.
Particularly in young infants, urination is usually not sufficiently predictable to provide warning or time for a caregiver to prepare to collect an uncontaminated and intact sample at the time urination occurs.
There are currently various devices and methods that that have been adopted by health care professionals to collect urine samples. These have included inserting extra absorbent material (such as cotton wadding) into a diaper proximate the discharge location; following a urination event, the material may be removed from the diaper and compressed to expel the absorbed urine into a sample container. Other methods have involved use of catheters (internal and external). These methods have not been entirely satisfactory; they have been deemed overly cumbersome, messy, or undesirably uncomfortable and/or invasive for the infant patient.
Currently available disposable absorbent diapers are not satisfactory for collecting uncontaminated and intact urine samples, because they do not isolate urine from fecal matter; they absorb aqueous liquid relatively quickly and do not readily release it; and they often include materials that can contaminate a urine sample and/or otherwise render it non-representative of its composition immediately following urination.
Therefore, there is room for improvement to methods and/or devices by which uncontaminated and intact urine samples may be collected from infants.
The term “hydrophilic” describes surfaces such as film or fiber surfaces, which are wettable by aqueous fluids (e.g., aqueous body fluids) deposited on these fibers. Hydrophilicity and wettability are typically defined in terms of contact angle and the strike through time of the fluids, for example through a nonwoven fabric. This is discussed in detail in the American Chemical Society publication entitled “Contact angle, wettability and adhesion”, edited by Robert F. Gould (Copyright 1964). A fiber or surface of a fiber is said to be wetted by a fluid (i.e., hydrophilic) when either the contact angle between the fluid and the fiber, or its surface, is less than 90°, or when the fluid tends to spread spontaneously across the surface of the fiber, both conditions are normally co-existing. Conversely, a fiber or surface of the fiber is considered to be hydrophobic/non-wettable if the contact angle is greater than 90° and the fluid does not spread spontaneously across the surface of the fiber.
The “liquid control structure” of a diaper includes all components and structure overlying a urine impermeable backsheet, and disposed along and straddling the longitudinal axis of the diaper, except for a topsheet. If the diaper includes a topsheet, the liquid control structure includes all components and structure disposed between the urine impermeable backsheet and the topsheet, and disposed along and straddling the longitudinal axis of the diaper. An absorbent core structure as typically appears in currently marketed disposable diapers is one type of “liquid control structure” as the latter term is used herein; however, a “liquid control structure” as the term is more broadly used herein may retainably absorb aqueous liquid, as will an absorbent core structure of a typical diaper, or may, alternatively, be adapted not to, or have a portion adapted not to, retainably absorb aqueous liquid. The liquid control structure of a diaper has a plan surface area when the diaper is laid out in extended and flat configuration on a horizontal surface, viewed from above along a direction orthogonal to the surface. The plan surface area also defines a volume of space, coextensive with the plan surface area in the x-y plane and quantified by the plan surface area and the average z-direction caliper or thickness of the liquid control structure.
“Length,” with respect to a diaper or a component thereof, refers to a dimension measured along a direction generally perpendicular to the waist edges of the diaper.
“Longitudinal,” with respect to a diaper or a component thereof, refers to a direction generally perpendicular to the waist edges of the diaper.
A “nonwoven” web material is a manufactured web of directionally or randomly oriented fibers consolidated into a web and bonded by friction, entanglement, thermal bonding, mechanical bonding, cohesion and/or adhesion, or any combination thereof. The term excludes film, paper and products which are woven, knitted or stitch-bonded. The fibers may be of natural or man-made (synthetic) origin. They may be staple fibers or continuous fibers. Nonwoven fabrics can be formed by processes such as but not limited to meltblowing, spunbonding, dry-laying, wet-laying and carding, and combinations thereof. The basis weight of nonwoven web materials is usually expressed in grams per square meter (gsm).
“Width,” with respect to a diaper or a component thereof, refers to a dimension measured along a direction generally parallel to the waist edges of the diaper.
“Lateral,” “transverse,” and forms thereof, with respect to a diaper or a component thereof, refers to a direction generally parallel to the waist edges of the diaper.
“Urine impermeable,” with respect to a sheet or layer component of a diaper positioned to receive urine, means that the urine will not pass through the sheet or layer from one side to the other, without application of an amount of pressure, exceeding atmospheric level, to the urine as it contacts the sheet or layer. A urine impermeable sheet or layer of material may be formed of a continuous, unapertured and non-porous polymer film; or a polymer film with apertures or pores that are sufficiently small in combination with sufficiently hydrophobic surface properties of the polymer such that urine will not pass through the apertures or pores without application of pressure; or a fibrous nonwoven web material having a combination of sufficiently small interstitial/intrafiber spaces or pores and sufficiently hydrophobic surface properties of the fibers such that urine will not pass through the apertures or pores without application of pressure. An apertured or porous sheet or layer of material may be urine impermeable as defined above, but may be permeable to water vapor.
“Urine permeable,” with respect to a sheet or layer component of a diaper positioned to receive urine, means that urine will pass through the sheet or layer from one side to the other, without application of an amount of pressure, exceeding atmospheric level, to the urine as it contacts the sheet or layer. A urine permeable sheet or layer of material may be formed of a polymer film, having apertures or pores that are sufficiently large, and/or having sufficiently hydrophilic surface properties, such that urine will pass through the apertures or pores without application of pressure. A urine permeable sheet or layer of material may be formed of a fibrous nonwoven web material, having sufficiently large apertures, interstitial/intrafiber spaces or pores, and/or having sufficiently hydrophilic surface properties of the fibers, such that urine will pass through the apertures or interstitial/intrafiber spaces or pores without application of pressure.
“Inboard” and “outboard” are relative terms relating the locations of two features of a diaper with respect to a longitudinal axis of the diaper. A first feature of a diaper is inboard of a second feature of the diaper, and the second feature is outboard of the first feature, when the first feature lies closer to the longitudinal axis of the diaper than the second feature.
“Underlie” and “overlie” (and forms thereof) refer to a vertical positional relationship between two components of a diaper that is open, extended and laid out flat on a horizontal surface with the wearer-facing surfaces facing up. With the diaper in this position, a first component overlies a second component, and the second component underlies the first component, when the first component lies directly or indirectly over or on top of the second component, or the second component lies directly or indirectly beneath the first component.
The terms “upper” and “lower,” and forms thereof, used with respect to components of a diaper, relate to the vertical direction and positioning of the components when the diaper is open, extended and laid out flat on a horizontal surface with the wearer-facing surfaces facing up. With respect to
“Wearer-facing,” with respect to a diaper or a component thereof, means the side of the diaper or component that faces the wearer's body when the diaper is worn in its normal configuration, with the backsheet to the outside. “Outward-facing” means the side of the diaper or component that faces away from the wearer when the diaper is worn in its normal configuration. In
“x-y plane”, used with respect to a diaper, relates to a plane parallel to a horizontal surface upon which the diaper may be opened, extended and laid out flat with the wearer-facing surfaces facing up. With respect to
“z-direction,” used with respect to a diaper, relates to the direction orthogonal to the x-y plane. With respect to
Description
Diaper 10 may including a pair of fastening members 50 extending laterally outboard of the main structure in the rear waist region 11. Fastening members 50 may be integral and/or contiguous with other components forming the diaper (such as the backsheet and/or topsheet), or may be separately formed and attached via bonds 53 as suggested in
Diaper 10 may have an outward-facing backsheet 14 and a wearer-facing topsheet 16. Backsheet 14 and topsheet 16 may be affixed together either directly, or with other layers interposed therebetween, to form an enveloped space therebetween. In one example, backsheet 14 and topsheet 16 may be affixed together partially or entirely about their peripheries by deposits of adhesive 54.
Backsheet
Diaper 10 may have an outer backsheet 14 that forms most of the outward-facing surfaces of the diaper when worn. Backsheet 14 may be urine impermeable and may be formed of a single layer of material or may be formed of a laminate of two or more layers of material. In one example, backsheet 14 may be formed of an inner layer of an effectively urine impermeable polymeric film, laminated with an outer layer of a nonwoven web material. An outer layer of nonwoven material may be included for purposes of enhancing tensile strength of the backsheet and/or for imparting a softer, more cloth-like feel and appearance to the backsheet. In another example, an effectively urine impermeable backsheet may be formed of a nonwoven web material alone, having at least a layer of closely-spaced, fine fibers such as meltblown fibers that are hydrophilic, e.g., in a spunbond-meltblown-spunbond (SMS) layered configuration. In a simpler example, backsheet 14 may be formed of a layer of polymeric film alone.
In disposable diapers, it is often desired that the backsheet have high opacity, for aesthetic purposes of concealment of the presence of exudates contained in the diaper while it is worn. However, for purposes of timely collection of a sample, in some examples it may be desired that the backsheet have sufficient translucency to enable easy visual detection of the presence of urine therein. Manipulation of opacity (conversely, translucency) by selection of material components, opacifying additives, and manufacturing techniques is well known in the art. For purposes of decreasing opacity/increasing translucency, opacifying additives (such as, for example, TiO2) may be minimized or even omitted entirely. Clarifying additives may be included in the resin formulations used to form the backsheet materials, e.g., backsheet film and/or nonwoven fibers. For purposes described above, it may be desired that the backsheet have an opacity of no greater than 50 percent, more preferably no greater than 45 percent, even more preferably no greater than 40 percent, and still more preferably no greater than 35 percent, as measured by the opacity test method described below.
Topsheet
Diaper 10 may include a liquid control structure 15 adapted to receive and control, and in some circumstances absorb and retain liquid exudates (e.g., urine). As may be seen in
Topsheet 16 may be formed of a urine permeable material, for example, a nonwoven material such as described in U.S. Pat. No. 8,968,614. For purposes of ensuring passage of urine through the topsheet 16 to the materials of the liquid control structure 15, thereby minimizing chances of loss or contamination of a urine sample, it may be desired that the topsheet 16 be formed of an apertured nonwoven material formed of fibers. The fiber constituents may be selected or manufactured to be inherently hydrophilic, or may be treated, e.g., with an application of a suitable surfactant, to impart hydrophilic surface properties. Suitable examples of apertured topsheets are described in U.S. Pat. Nos. 7,033,340; 6,680,422; 6,498,284; 6,414,215; 5,516,572; and 5,342,338; and in pending U.S. application Ser. No. 14/270,468. In one example, synthetic polymer fiber constituents of a topsheet, such as fibers spun from polypropylene and/or polyethylene resin (ordinarily hydrophobic materials) may be treated to impart them with hydrophilic surfaces using the materials and method described in, for example, U.S. App. Pub. No. 2011/0015602. Following such treatment, the hydrophilizing materials are cross-linked and/or chemically grafted to the fiber constituents, such that they do not wash off (i.e., dissolve) in aqueous liquid (e.g., urine).
In another example, topsheet 16 may be formed of an apertured film. Use of an apertured film may be preferred, for example, in diapers for use with premature or very young and/or relatively small infants. Such diapers are typically assigned a size designation of 2 or lower, 1 or lower, or even 0 or lower. Such infants usually have relatively small bladder capacity and may discharge only small quantities of urine (e.g., less than about 50 mL) in a single urination event. The benefit of an apertured film topsheet is that it may be less likely and/or capable of retainably absorbing a substantial quantity of urine, than a topsheet formed of a fibrous nonwoven material. In a more specific example, topsheet 16 may be formed of an apertured formed film, or in an even more specific example, a vacuum formed apertured film. Features of suitable examples of apertured films are commonly found in topsheets in currently marketed feminine hygiene pads, and are also disclosed in, for example, U.S. Pat. Nos. 8,679,391; 6,471,716; 6,989,187 and 4,629,643; and U.S. Pat. App. Pub. No. 2015/0273793.
As will be further appreciated from the description below, in some examples of the diaper herein, and in contrast to conventional disposable diapers, the patient-wearer's urine might not be absorbed in a structure beneath the topsheet to a substantial degree. Rather, following discharge, the urine may flow through the topsheet and be held substantially unabsorbed in the enveloped space between the topsheet and backsheet, until the diaper is removed from the wearer and the urine is poured out into a sample container. Therefore, it may be desired that the topsheet be adapted to permit the urine to move relatively freely after discharge, from the wearer-facing side of the topsheet through to the outward-facing side of the topsheet and into the envelope space, but to obstruct or inhibit urine flow back through the topsheet from the envelope space toward the wearer.
In one example suitable for such purpose, an apertured film topsheet may be used, particularly one having a pattern of apertures 36 that are defined by funnel structures 37 as depicted in
In some circumstances, it may be desired that a film topsheet not be included. Rather, a topsheet formed of nonwoven web, or even no top sheet overlying the liquid control structure, may be desirable. Particularly when use with premature infants is contemplated, a film topsheet may present a risk of sticking to the skin, which may be undesirable in some circumstances because a premature infant's skin may be very delicate.
Urine Capture Layer
As discussed above, topsheet 16, which may be adapted to allow discharged urine to freely pass therethrough, may be desired. Additionally, it may be desired that the diaper include a urine capture layer 34 beneath the topsheet 16 and above the backsheet 14.
Urine capture layer 34 may be included and may serve one or more functions: (1) to provide an open structure that occupies a volume, and thereby ensures the presence of space within the envelope structure between topsheet 16 and backsheet 14, available to receive urine while the diaper is being worn by an infant; (2) to absorb and disperse kinetic energy in a gush of urine during discharge by the wearer, thereby slowing and controlling flow thereof inside the diaper and reduce the chances of a leak; and (3) to provide a matrix structure that holds urine and restricts rapid flow back and forth within the volume occupied by the layer, reducing the chances of a leak, prior to the time the diaper is removed for urine sample retrieval.
Because a purpose of the diaper 10 as described herein may be to initially receive and collect, but then release, urine to be sampled upon removal from the patient, it may be desired that urine capture layer 34 does not have substantially absorbent properties. This may be particularly important for younger infant patients, who urinate in only relatively small volumes at a time. Accordingly, it may be desired that urine capture layer 34 be formed of or include a batt or pad of accumulated synthetic fibers spun from suitable polymeric resin(s), or a single- or multilayer section of fibrous nonwoven web material comprising fibers spun or otherwise formed of such resin(s). The resin(s) may be selected such that the fibers formed therefrom have hydrophobic surface properties, and thereby do not tend to attract or retainably hold aqueous liquid in the interstitial spaces within the fiber matrix, or otherwise, freely give up deposits of aqueous liquid upon light compression (light squeezing, rolling or wringing) of the diaper. Suitable materials and additives for forming a urine capture layer 34 are described in, for example, U.S. Pat. No. 8,598,406 and US 2004/4158213. If desired, additives and/or treatments that render the fibers hydrophilic may be omitted, to reduce the absorbency of the layer 34. Examples of suitable synthetic, hydrophobic fibers which may be used to form all or a portion of a urine capture layer include fibers formed of one or more polyolefins (polyethylene and polypropylene). Alternatively, to promote distribution of discharged urine within the volume occupied by the liquid control structure, thereby enhancing capacity, urine capture layer 34 may be formed of or include a batt or pad (one or more layers thereof) including synthetic fibers spun or otherwise formed of materials that yield fibers that have hydrophilic surface properties. In addition to enhancing capacity, by having some attraction for aqueous liquid, hydrophilic fibers may reduce uncontrolled movement of urine back and forth within the liquid control structure. Non-limiting examples of synthetic materials that may be used to form such fibers include polyamides (e.g., nylon); polyesters (e.g., polyethylene terephthalate (PET)); polylactic acid (PLA); rayon; viscose and lyocell. In one example, urine capture layer 34 may include a blend of both hydrophilic synthetic fibers and hydrophobic fibers (such as fibers spun from polyolefins such as polypropylene and/or polyethylene). In another example, a multi-layered structure including, e.g., a layer formed predominately of synthetic hydrophobic fibers, and a layer formed predominately of hydrophobic fibers, to balance performance with respect to effective distribution of urine through the liquid control layer, and a desired level of non-absorbency and/or average Liquid Release Ratio for the diaper (described below).
Other naturally hydrophilic fiber components may be included in the urine capture layer following urination. Such components may include natural fibers, including but not limited to cellulosic fibers such as wood pulp fibers (included treated wood fibers) and cotton fibers, flax, linen and hemp fibers, and animal fibers such as wool, silk, fur and hair fibers. In another alternative, it may be desired to treat hydrophobic material(s) forming urine capture layer 34 with a surfactant composition to render their surfaces hydrophilic. In one example, synthetic polymer fiber constituents of a urine capture layer 34, such as fibers spun from polypropylene and/or polyethylene resin (ordinarily hydrophobic materials) may be treated to impart them with hydrophilic surfaces using the materials and method described in, for example, U.S. App. Pub. No. 2011/0015602. Following such treatment, the hydrophilizing materials are cross-linked and/or chemically grafted to the fiber constituents, such that they do not wash off (i.e., dissolve) in aqueous liquid (e.g., urine).
In another example, or in combination, synthetic polymer fiber constituents of a urine capture layer 34, such as fibers spun from polypropylene and/or polyethylene resin (ordinarily hydrophobic materials) may be treated to impart them with hydrophilic surfaces by application of one or more of the materials described in, for example, U.S. Pat. No. 8,178,748. The '748 patent identifies materials such as ARLAMOL PS15E (a PPG-15 stearyl ether formulation currently available from Croda International Plc, East Yorkshire, UK). Such a material may provide an advantage in that it imparts hydrophilicity to the surfaces of synthetic polymer fibers, while being insoluble in water and tending to remain adhered to the fiber surfaces, and thus may not dissolve or become dispersed in the desired urine sample and thereby contaminate it. Other materials that may have similar properties and advantages may include, but are not limited to, those comprising functionalities of polyethylene glycol (PEG), polypropylene glycol (PPG), and polybutylene glycol (PBG) functional groups can be used to treat a portion of the nonwoven 24 to form the hydrophilic zone 37. Nonionic surfactants having a functional group selected from the group consisting of polyethylene glycol (PEG), polypropylene glycol (PPG), polybutylene glycol (PBG), and combinations thereof can be used to treat a portion of the nonwoven 24 to form the hydrophilic zone 37. The degree of polymerization of a polyether functional group in a non-ionic surfactant can be between about 2 and about 100. Because examples of such materials may be relatively stable, oily liquids that do not evaporate at room temperature within time periods in circumstances contemplated herein, it may be desired that they be applied to surfaces underlying a topsheet or other wearer-facing surface or layer, so as not to be susceptible to being rubbed off by contact with the wearer.
In in conjunction with the inclusion of a soluble surfactant composition or other soluble additives, the diaper 10 can be provided with associated packaging, package insert or other media bearing information effective to notify health care and/or analytical personnel of the inclusion of the soluble surfactant composition in the diaper. Alternatively, such information may be printed on the diaper itself, in a suitably noticeable and visible location.
To reduce or prevent opportunity for substantial retaining absorption of the urine, it may be desired that the liquid control structure 15 not contain a substantial quantity of water-absorbent material of the types typically used in absorbent storage layers of disposable diapers, disposable absorbent pants and other absorbent personal hygiene products, i.e., cellulose fibers; cotton fibers, other plant fibers, absorbent sponge; absorbent foam; superabsorbent polymer; absorbent gelling material; hydrogel-forming particles; and/or absorbent polymer particles collectively herein, “absorbent material”. (The term “absorbent material” as used herein is not intended to include materials not listed in the preceding sentence.) Thus, it may be desired that the volume of the liquid control structure coextensive with at least 50 percent of the plan surface area of the liquid control structure contains no more than 50 percent, more preferably no more than 35 percent, even more preferably no more than 20 percent, or 10 percent, or 5 percent and still more preferably no more than an insubstantial quantity or even about 0 percent, by weight absorbent material. It may be even further preferred that the volume of the liquid control structure coextensive with at least 65 percent, or 80 percent, 90 percent, 95 percent or even substantially all of the plan surface area of the liquid control structure contains no more than 50 percent, more preferably no more than 35 percent, even more preferably no more than 20 percent, or 10 percent, or 5 percent and still more preferably no more than an insubstantial quantity or even about 0 percent, by weight absorbent material.
It may be appreciated that the liquid control structure 15, and more particularly the urine capture layer 34, may be formed of a variety of materials in a variety of sizes and/or shapes that can serve functions of a urine capture layer identified above, while avoiding stubbornly retaining absorption of urine. Accordingly, when use for obtaining a urine sample is a primary purpose of the diaper 10, it may be desired that the product have an average Liquid Release Ratio of at least 3 percent, more preferably at least 5 percent, even more preferably at least 15 percent, 25 percent, 35 percent, 45 percent, and still more preferably at least 50 percent, as measured by the Liquid Release Ratio Test Method described below. Providing a diaper product having storage space for urine provided by an envelope structure and a urine capture layer, but having limited absorption tendency, ensures that a substantial portion of urine deposited in such diaper by the wearer is recoverable by the caregiver for sampling purposes.
For purpose of obtaining a urine sample that accurately represents the urine at the time of discharge, it may be desired that the envelope space between the topsheet and backsheet contain no more than an insubstantial quantity of water-soluble materials. As a reflection of the absence of a substantial quantity of water-soluble materials, for purposes herein, purified water deposited into the diaper and then emptied out of the diaper will exhibit a conductivity no greater than 1 S/m (siemens/meter), more preferably no greater than 0.1 S/m, and even more preferably no more than 0.01 S/m, measured according to the Conductivity Test specified below. Alternatively, or in combination, the emptied water will exhibit a surface tension from 20 mN/m (milli-Newton/meter) to 72 mN/m, more preferably from 30 mN/m to 72 mN/m, even more preferably from 40 mN/m to 72 mN/m, and still more preferably from 50 mN/m to 72 mN/m, measured according to the Surface Tension Test specified below.
Longitudinal Cuffs
Diaper 10 may include a pair of standing longitudinal cuffs 18. Such cuffs are currently common in disposable diapers and are variously known as gasketing cuffs, standing cuffs, barrier cuffs, etc. Longitudinal cuffs 18 may be formed of a fibrous nonwoven material, a polymeric film material, or a laminate thereof. In one example, longitudinal cuffs 18 may be formed of an effectively urine impermeable material, which will serve to prevent escape of urine collected in the diaper. Non-limiting examples of suitable materials for forming longitudinal cuffs are described in U.S. Pat. No. 7,695,463.
As reflected in
As may be appreciated from
This combination of cuff end/edge bonds 22 and pre-strained longitudinal cuff elastic members 19 can cause the cuffs 18 to stand as described above regardless of whether the edges 20 and end/edge bonds 22 are disposed inboard, or outboard, of the affixed proximal portions 21 of the cuffs. In the example depicted in
Elastic members 19 may be discontinuously or continuously adhered along their lengths to the material(s) forming cuff 18 structures by, e.g., adhesive applied by strand-coating the elastic members. In some examples the material forming the cuffs 18 may be folded over the elastic members 19 to better contain them and restrain them within the structure in the event of failure of the adhesive. This has the further advantage of providing a folded (rather than cut) material edge as distal edge 20, providing a neat appearance and softer feel.
In some examples it may be desired that topsheet 16 and longitudinal cuffs 18 are continuously integrally joined where they meet, thereby preventing escape of liquid at the junction therebetween. In one example, an effectively urine impermeable sheet or web material (such as a polymer film) forming topsheet 16 in whole or in part may contiguously form a portion or layer of each longitudinal cuff 18. The topsheet can be provided with a pattern of apertures to render it urine permeable in a zone or region overlying the liquid control structure 15.
In a simplified example made more apparent in
In another example apparent in
Waistband Member
As reflected in
Waistband member 28 may be disposed in the rear waist region 11 of the diaper, over the topsheet 16. However, it may also be disposed in the front waist region 12. It may be formed of any suitable web material. In one example, it may be formed of a nonwoven web material.
Waistband member 28 may be affixed to the diaper structure by mechanical or thermal bonding, by adhesive or other means, or a combination thereof. As may be appreciated from
As suggested in
When a diaper having a spout structure as described, and containing a quantity of urine following a urination event, is removed from a wearer-patient and tilted, wearer-facing surface up, toward the spout structure, the urine will tend to flow by gravity into the spout structure. This concentrates the exiting flow of the urine past the waist edge and facilitates neat pouring of the urine into a sample container.
Urine Outlet
When the topsheet 16 selected for diaper 10 is highly or effectively urine permeable for flow therethrough in both directions, it may be unnecessary to include any supplementary features to facilitate release of captured urine from the front or rear waist region of the diaper via tilting with or without compression, as described herein. However,
Exudates Indicator
It may be desired that the diaper 10 include a wetness indicator 40 (see, e.g.,
The wetness indicator may have any form, composition or configuration suitable for a relatively prompt response. In one example, a wetness indicator may include a material applied or affixed to the wearer-facing surface of the backsheet 14, in the envelope space between the topsheet and the backsheet where urine will be received. In another example, a wetness indicator may include an indicator material applied or affixed to an outward-facing surface of the liquid control structure 15. The indicator material may include a composition selected, formulated and/or adapted to visibly change appearance when wetted, or when warmed by contact with recently discharged urine. The appearance change may be one or more of a change in color, appearance or disappearance of a visible element, or any other visible change that occurs when the composition is wetted or warmed by contact with urine. The material(s) forming urine impermeable backsheet 14 may be selected to have sufficient translucence (e.g., sufficiently low opacity) to enable effectively clear visibility of the wetness indicator on the outside of the diaper, in combination with the materials, composition, configuration and placement location of the wetness indicator 40. Non-limiting suitable examples of wetness indicators are described in U.S. provisional application Ser. Nos. 62/147,258 and 62/186,406. Other non-limiting suitable examples are described in U.S. Pat. Nos. 8,927,801; 8,618,349; 7,332,642; 7,159,532; 6,075,178; and 4,231,370; and U.S. published application nos. 2015/173968; 2013/116644; 2011/137274; and 2004/4254549.
In other examples, an included wetness indicator may operate to electrically/electronically trigger a visible and/or audible signal when the diaper is wetted. In some examples, a combination of a sensing device or devices included in components of the diaper that will be exposed to wetness, and a signal-receiving/processing device, may be included. In such examples, the sensing device in the diaper generates or triggers a signal indicative of a wetted condition, and the signal-receiving/processing device receives the signal and provides a visible and/or audible signal to the caregiver. In some examples, the signal-receiving/processing device may be remote from the diaper and may be carried about by the caregiver. Non-limiting examples are described in U.S. Pat. Nos. 9,241,839 and 6,603,403; and U.S. Pat. App. Pub. Nos. US2010/0030173 and US2010/0164733. Various improvements and variations of such examples as well as other configurations of diaper wetness detection devices are described and known in the art.
In still other examples, it may be desired that the diaper include a device adapted to detect, and cause generation of a visible and/or audible signal of, the presence of stool in the diaper. This may provide a means of facilitating prompt removal of the diaper to reduce chances of contamination of a urine sample by constituents of the wearer's feces. Non-limiting examples are described in U.S. Pat. No. 8,933,292.
Packaging Configuration and Information
It may be desirable to provide a separate package for each individual diaper. A diaper as described herein may be deemed a product for medical use or treatment. Thus, individual packaging of each diaper may be desirable for purposes of actually or perceivably maintaining a level of sterility, cleanliness, purity and structural integrity of each individual diaper until use, in a manner similar to the manner in which, e.g., individual bandages are packaged. A supply of individually packaged diapers may be packaged as a group in a larger outer package.
As noted previously, in the event that a composition, for example, a water-soluble surfactant, is included in or on materials within the envelope space between the topsheet and backsheet, it may be desirable to include information with the packaging associated with the diaper, or even on the diaper itself, effective to notify health care and/or analytical personnel of the inclusion of the composition in the diaper. Other information useful for enabling health care and/or analytical personnel to identify, quantify or isolate components or attributes of the urine recovered from the diaper may also be included with the packaging. In one additional non-limiting example, the weight of the individual diaper may be recorded on the diaper, the packaging or on material(s) included/associated with the packaging. This will enable the caregiver to calculate the quantity by weight of urine discharged by the patient, from, e.g., the weight of the diaper prior to use, and the measured weight of the diaper after its removal from the wearer following a urination event, prior to taking of a urine sample from the diaper. In one example, such information may be printed on the diaper itself, such as on an outward-facing surface of the backsheet or a visible layer thereof.
It may also be desirable to include information and/or indicia associated with the diaper, individual packaging (if included) or outer packaging, identifying the diaper as a special-use diaper, and distinguishing it from ordinary diapers. This will serve to notify healthcare professionals or other caregivers of the special design of the diaper, and help avoid confusion, inappropriate use of the special-use diaper for ordinary purposes, and intermixing of supplies of the special-use diapers with supplies of ordinary diapers.
Non-Invasive Method for Obtaining a Urine Sample from an Infant
Utilizing a suitable example of a diaper 10 as described herein, a caregiver may obtain a sample of urine from an infant patient by the following steps:
The above-described method, employing any example of a diaper described herein, may provide improved facilitation in obtaining a urine sample from an infant, without the need for invasive devices or techniques, or the application of an adhesive to the infant's skin.
Liquid Release Ratio Test Method
The Liquid Release Ratio Test Method measures the volume of saline solution that can be drained from a diaper after loading it with a known volume of saline solution.
Begin by removing the individual diaper samples from any packaging, and allow them to precondition at 25° C.±2 C.° and 50%±2% relative humidity for 2 hours prior to testing. Testing is performed under these same conditions. Following preconditioning, each diaper is tested as follows. Saline solution or water used for testing also should be at a temperature of 25° C.±2 C°.
Calculate the liquid release ratio for the sample as the volume of saline solution drained from the diaper, divided by 30 mL, and multiplying by 100%.
Repeat this procedure for 10 diaper samples. Calculate the average Liquid Release Ratio exhibited by the 10 samples and report the value to the nearest 0.1%.
Conductivity Test Method
To obtain the test samples, follow all steps of the Liquid Release Ratio Test Method, above, except substitute Type 1 reagent grade water for saline solution, in Step 6. Step 9 (volume measurement), and the liquid release ratio calculation, are not required.
Ensure that the liquid sample drained from the diaper is at a temperature of 25° C. Measure the conductivity of a sample obtained from each of 10 diaper samples, and record and calculate the average of the results. Conductivity may be measured using any suitable device adapted for this purpose, and adapted for testing for values within the ranges set forth in the specification above, for example, a conductivity meter available from Myron L Company, Carlsbad, California
Surface Tension Test Method
To obtain the test samples, follow all steps of the Liquid Release Ratio Test Method, above, except substitute Type 1 reagent grade water for saline solution, in Step 6. Step 9 (volume measurement), and the liquid release ratio calculation, are not required.
Ensure that the liquid sample drained from the diaper is at a temperature of 25° C. Measure the surface tension of a sample obtained from each of 10 diaper samples, and record and calculate the average of the results. Surface tension may be measured using any suitable device adapted for this purpose, and adapted for testing for values within the ranges set forth in the specification above, for example, a surface tensiometer available from Kibron Inc., Helsinki, Finland.
Opacity Test Method
The opacity of a backsheet material is the degree to which light is blocked by that material. A higher opacity value indicates a higher degree of light block by the material. Opacity may be measured using a 0° illumination/45° detection, circumferential optical geometry, spectrophotometer with a computer interface such as the HunterLab LabScan XE running Universal Software (available from Hunter Associates Laboratory Inc., Reston, VA). Instrument calibration and measurements are made using the standard white and black calibration plates provided by the vendor. All testing is performed in a room maintained at about 23±2° C. and about 50±2% relative humidity.
Configure the spectrophotometer for the XYZ color scale, D65 illuminant, 10° standard observer, with UV filter set to nominal. Standardize the instrument according to the manufacturer's procedures using the 1.20 inch port size and 1.00 inch area view. After calibration, set the software to the Y opacity procedure.
To obtain the specimen, lay the diaper sample flat on a bench, body facing surface downward, and measure the total longitudinal length of the diaper. Note a site 33% of the total length from the rear waist edge of the diaper along the longitudinal axis. Carefully remove the backsheet including any and all laminate components thereof, from the outward-facing side of the diaper. A cryogenic spray, such as Cyto-Freeze (obtained from Control Company, Houston, TX), may be used to separate the backsheet laminate from the other components of the diaper. Cut a piece 50.8 mm by 50.8 mm centered at the site identified above. Precondition specimens at about 23° C.±2 C.° and about 50%±2% relative humidity for 2 hours prior to testing.
Place the specimen over the measurement port. The specimen should completely cover the port with the surface corresponding to the garment-facing surface of the diaper directed toward the port. Cover the specimen with the white standard plate. Take a reading, then remove the white tile and replace it with black standard tile without moving the specimen. Obtain a second reading, and calculate the opacity as follows:
Opacity=Y value(black backing)/Y value(white backing)×100
A total of 10 identical diapers are analyzed and their opacity results recorded. Calculate and report the average opacity and standard deviation for the 10 backsheet laminate measurements to the nearest 0.01%.
In view of the foregoing description, the following non-limiting, non-exclusive examples are contemplated:
The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value.
Every document cited herein, including any cross referenced or related patent or application is hereby incorporated herein by reference in its entirety unless expressly excluded or otherwise limited. The citation of any document is not an admission that it is prior art with respect to any invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches, suggests or discloses any such invention. Further, to the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
This application is a continuation of U.S. application Ser. No. 15/446,077, filed on Mar. 1, 2017, which claims the benefits of U.S. Provisional Applications No. 62/301,679, filed Mar. 1, 2016, and No. 62/315,961, filed Mar. 31, 2016, the substances of each of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2610629 | Hawkins | Sep 1952 | A |
3776233 | Schaar | Dec 1973 | A |
3918433 | Fuisz | Nov 1975 | A |
4231370 | Mroz | Nov 1980 | A |
4257418 | Hessner | Mar 1981 | A |
4629643 | Curro | Dec 1986 | A |
4661102 | Shikata et al. | Apr 1987 | A |
4778459 | Fuisz | Oct 1988 | A |
5026364 | Robertson | Jun 1991 | A |
5222809 | Ehrenkranz | Jun 1993 | A |
5226992 | Morman | Jul 1993 | A |
5342338 | Roe | Aug 1994 | A |
5516572 | Roe | May 1996 | A |
5714156 | Schmidt et al. | Feb 1998 | A |
5827259 | Laux | Oct 1998 | A |
5906604 | Roennberg et al. | May 1999 | A |
5931827 | Buell et al. | Aug 1999 | A |
5934470 | Bauer et al. | Aug 1999 | A |
5938652 | Sauer | Aug 1999 | A |
5971970 | Carlbark et al. | Oct 1999 | A |
5993433 | St | Nov 1999 | A |
5998695 | Roe et al. | Dec 1999 | A |
6010490 | Freeland et al. | Jan 2000 | A |
6010491 | Roe et al. | Jan 2000 | A |
6018093 | Roe et al. | Jan 2000 | A |
6075178 | La | Jun 2000 | A |
6120486 | Toyoda et al. | Sep 2000 | A |
6132410 | Gompel et al. | Oct 2000 | A |
6135988 | Turner et al. | Oct 2000 | A |
6217563 | Gompel et al. | Apr 2001 | B1 |
6296862 | Paul | Oct 2001 | B1 |
6315764 | Faulks et al. | Nov 2001 | B1 |
6336922 | Vangompel et al. | Jan 2002 | B1 |
6372952 | Lash et al. | Apr 2002 | B1 |
6395955 | Roe et al. | May 2002 | B1 |
6414215 | Roe | Jul 2002 | B1 |
6471716 | Pecukonis | Oct 2002 | B1 |
6491677 | Glaug et al. | Dec 2002 | B1 |
6498284 | Roe | Dec 2002 | B1 |
6551295 | Schmidt et al. | Apr 2003 | B1 |
6570057 | Schmidt et al. | May 2003 | B1 |
6603403 | Jeutter et al. | Aug 2003 | B2 |
6627786 | Roe et al. | Sep 2003 | B2 |
6638262 | Suzuki et al. | Oct 2003 | B2 |
6659993 | Minato | Dec 2003 | B2 |
6664439 | Arndt et al. | Dec 2003 | B1 |
6680422 | Roe | Jan 2004 | B2 |
6720471 | Arndt et al. | Apr 2004 | B1 |
6767344 | Suzuki | Jul 2004 | B2 |
6786895 | Schmitz | Sep 2004 | B1 |
6790203 | Een | Sep 2004 | B2 |
6817993 | Simmons et al. | Nov 2004 | B1 |
6921394 | Sayama et al. | Jul 2005 | B2 |
6989187 | Thomas | Jan 2006 | B2 |
7033340 | Muscat et al. | Apr 2006 | B1 |
7118557 | Minato et al. | Oct 2006 | B2 |
7159532 | Klofta et al. | Jan 2007 | B2 |
7163530 | Toyoshima et al. | Jan 2007 | B1 |
7332642 | Liu | Feb 2008 | B2 |
7419562 | Van | Sep 2008 | B2 |
7566330 | Sugiyama et al. | Jul 2009 | B2 |
7666173 | Mishima et al. | Feb 2010 | B2 |
7695463 | Lavon et al. | Apr 2010 | B2 |
7744576 | Busam | Jun 2010 | B2 |
7753899 | Mori et al. | Jul 2010 | B2 |
7772455 | Roe et al. | Aug 2010 | B1 |
7785309 | Van et al. | Aug 2010 | B2 |
7794441 | Ashton et al. | Sep 2010 | B2 |
7838722 | Blessing et al. | Nov 2010 | B2 |
7838723 | Schmidt et al. | Nov 2010 | B1 |
7879017 | Tabata | Feb 2011 | B1 |
8017827 | Hundorf et al. | Sep 2011 | B2 |
8043272 | Long et al. | Oct 2011 | B2 |
8178748 | Hammons et al. | May 2012 | B2 |
8180603 | Blessing et al. | May 2012 | B2 |
8181278 | Odorzynski et al. | May 2012 | B2 |
8216201 | Beck | Jul 2012 | B2 |
8231592 | Suzuki et al. | Jul 2012 | B2 |
8274393 | Ales et al. | Sep 2012 | B2 |
8430858 | Baeck | Apr 2013 | B2 |
8449518 | Allison-Rogers | May 2013 | B2 |
8496637 | Hundorf et al. | Jul 2013 | B2 |
8502012 | Meyer et al. | Aug 2013 | B2 |
8581019 | Carlucci et al. | Nov 2013 | B2 |
8598406 | Ponomarenko et al. | Dec 2013 | B2 |
8618349 | Klofta | Dec 2013 | B2 |
8668680 | Ichikawa et al. | Mar 2014 | B2 |
8679391 | O'Donnell et al. | Mar 2014 | B2 |
8747380 | Coates | Jun 2014 | B2 |
8764721 | Van Gompel | Jul 2014 | B2 |
8764722 | Rhein et al. | Jul 2014 | B2 |
8894626 | Beck | Nov 2014 | B2 |
8926580 | Carney et al. | Jan 2015 | B2 |
8927801 | Klofta | Jan 2015 | B2 |
8929944 | Yam | Jan 2015 | B2 |
8933292 | Abraham et al. | Jan 2015 | B2 |
8939562 | Koike et al. | Jan 2015 | B2 |
8968614 | Desai et al. | Mar 2015 | B2 |
8968814 | Heino et al. | Mar 2015 | B2 |
8979815 | Roe et al. | Mar 2015 | B2 |
8992496 | Back | Mar 2015 | B2 |
9044358 | Nakajima et al. | Jun 2015 | B2 |
9050218 | Martynus et al. | Jun 2015 | B2 |
9050219 | Martynus et al. | Jun 2015 | B2 |
9060904 | Hundorf et al. | Jun 2015 | B2 |
9072634 | Hundorf et al. | Jul 2015 | B2 |
9125758 | Skreosen | Sep 2015 | B2 |
9168181 | Popp et al. | Oct 2015 | B2 |
9216116 | Roe et al. | Dec 2015 | B2 |
9241839 | Abraham et al. | Jan 2016 | B2 |
9259362 | Popp et al. | Feb 2016 | B2 |
9445951 | Moberg-Alehammar et al. | Sep 2016 | B2 |
9464369 | Isele et al. | Oct 2016 | B2 |
9486368 | Nelson | Nov 2016 | B2 |
9554948 | Song et al. | Jan 2017 | B2 |
9675503 | Carney | Jun 2017 | B2 |
9713557 | Arizti et al. | Jul 2017 | B2 |
9789009 | Joseph | Oct 2017 | B2 |
20010053902 | Roe et al. | Dec 2001 | A1 |
20020013568 | Cinelli et al. | Jan 2002 | A1 |
20020035354 | Mirle et al. | Mar 2002 | A1 |
20020091368 | Beck et al. | Jul 2002 | A1 |
20020111596 | Fletcher | Aug 2002 | A1 |
20030050616 | Reynolds | Mar 2003 | A1 |
20040102757 | Olson | May 2004 | A1 |
20040158213 | Ponomarenko et al. | Aug 2004 | A1 |
20040230171 | Ando | Nov 2004 | A1 |
20040254549 | Olson et al. | Dec 2004 | A1 |
20060004340 | Ben-Natan | Jan 2006 | A1 |
20060048880 | Blessing | Mar 2006 | A1 |
20060247597 | Hogan et al. | Nov 2006 | A1 |
20070049895 | Van et al. | Mar 2007 | A1 |
20070088310 | Sugiyama et al. | Apr 2007 | A1 |
20070093767 | Carlucci et al. | Apr 2007 | A1 |
20070232180 | Polat et al. | Oct 2007 | A1 |
20070233027 | Roe et al. | Oct 2007 | A1 |
20080091159 | Carlucci et al. | Apr 2008 | A1 |
20080269706 | Long | Oct 2008 | A1 |
20080269707 | Song | Oct 2008 | A1 |
20080312619 | Ashton et al. | Dec 2008 | A1 |
20080312620 | Ashton et al. | Dec 2008 | A1 |
20080312621 | Hundorf et al. | Dec 2008 | A1 |
20080312622 | Hundorf | Dec 2008 | A1 |
20080312625 | Hundorf et al. | Dec 2008 | A1 |
20080312628 | Hundorf et al. | Dec 2008 | A1 |
20090138884 | Kakeda et al. | May 2009 | A1 |
20090318884 | Meyer et al. | Dec 2009 | A1 |
20100030173 | Song et al. | Feb 2010 | A1 |
20110015602 | Schmidt et al. | Jan 2011 | A1 |
20110137274 | Klofta | Jun 2011 | A1 |
20110184372 | Esping | Jul 2011 | A1 |
20120032319 | Dunipace | Feb 2012 | A1 |
20120141128 | Bai et al. | Jun 2012 | A1 |
20120277713 | Raycheck | Nov 2012 | A1 |
20120316526 | Rosati et al. | Dec 2012 | A1 |
20120316528 | Kreuzer et al. | Dec 2012 | A1 |
20120323195 | Ehmsperger et al. | Dec 2012 | A1 |
20130006206 | Wada et al. | Jan 2013 | A1 |
20130079740 | Ehmsperger et al. | Mar 2013 | A1 |
20130110065 | Takahashi et al. | May 2013 | A1 |
20130116644 | Wei et al. | May 2013 | A1 |
20130137274 | Takahashi | May 2013 | A1 |
20130331806 | Rosati et al. | Dec 2013 | A1 |
20140005622 | Wirtz | Jan 2014 | A1 |
20140005623 | Wirtz et al. | Jan 2014 | A1 |
20140068839 | Steele et al. | Mar 2014 | A1 |
20140107605 | Schroer, Jr. | Apr 2014 | A1 |
20140121487 | Faybishenko et al. | May 2014 | A1 |
20140142528 | Wang et al. | May 2014 | A1 |
20140142529 | Cheng | May 2014 | A1 |
20140155856 | Ronnberg et al. | Jun 2014 | A1 |
20140163501 | Ehrnsperger et al. | Jun 2014 | A1 |
20140163503 | Arizti | Jun 2014 | A1 |
20140221956 | Martynus et al. | Aug 2014 | A1 |
20140303589 | Paz et al. | Oct 2014 | A1 |
20140336605 | Hardie et al. | Nov 2014 | A1 |
20140345034 | Hansson et al. | Nov 2014 | A1 |
20140350508 | Popp | Nov 2014 | A1 |
20140371701 | Bianchi | Dec 2014 | A1 |
20150045759 | Martynus et al. | Feb 2015 | A1 |
20150045760 | Martynus et al. | Feb 2015 | A1 |
20150045761 | Martynus et al. | Feb 2015 | A1 |
20150051510 | Husmark et al. | Feb 2015 | A1 |
20150065973 | Roe et al. | Mar 2015 | A1 |
20150088086 | Beck | Mar 2015 | A1 |
20150157251 | Nelson | Jun 2015 | A1 |
20150173968 | Joseph | Jun 2015 | A1 |
20150209195 | Martynus et al. | Jul 2015 | A1 |
20150223996 | Martynus et al. | Aug 2015 | A1 |
20150257946 | Martynus et al. | Sep 2015 | A1 |
20150273793 | Thomas | Oct 2015 | A1 |
20150282997 | Arizti | Oct 2015 | A1 |
20150282998 | Arizti et al. | Oct 2015 | A1 |
20150282999 | Arizti | Oct 2015 | A1 |
20150313770 | Hubbard, Jr. et al. | Nov 2015 | A1 |
20160038350 | Martynus | Feb 2016 | A1 |
20160278992 | Martynus et al. | Sep 2016 | A1 |
20160278993 | Martynus et al. | Sep 2016 | A1 |
20160278994 | Martynus et al. | Sep 2016 | A1 |
20160303275 | Joseph et al. | Oct 2016 | A1 |
20170003257 | Klofta et al. | Jan 2017 | A1 |
20170246052 | Ludwig | Aug 2017 | A1 |
20170252015 | Barnhorst | Sep 2017 | A1 |
20170252233 | Barnhorst | Sep 2017 | A1 |
20180289562 | Inoue | Oct 2018 | A1 |
20180368817 | Tally | Dec 2018 | A1 |
20180369029 | Barnhorst et al. | Dec 2018 | A1 |
Number | Date | Country |
---|---|---|
204274811 | Apr 2015 | CN |
3072487 | Sep 2016 | EP |
1170784 | Feb 2017 | ES |
1229858 | Sep 1960 | FR |
77546 | Mar 1962 | FR |
H10295723 | Nov 1998 | JP |
1020100086255 | Jan 2009 | KR |
199856327 | Dec 1998 | WO |
09155265 | Dec 2009 | WO |
2016122152 | Aug 2016 | WO |
Entry |
---|
All Office Actions; U.S. Appl. No. 17/458,638, filed on Aug. 27, 2021. |
U.S. Appl. No. 17/458,638, filed on Aug. 27, 2021, to Jacob Alan Barnhorst et. al. |
U.S. Appl. No. 16/016,973, filed Jun. 25, 2018, Jacob Alan Barnhorst et al. |
All Office Actions for U.S. Appl. No. 15/446,077. |
All Office Actions for U.S. Appl. No. 16/002,244. |
All Office Actions for U.S. Appl. No. 16/016,973. |
All Office Actions for U.S. Appl. No. 15/234,540 filed Aug. 11, 2016. |
All Office Actions for U.S. Appl. No. 15/444,012 filed Feb. 23, 2017. |
All Office Actions, U.S. Appl. No. 15/234,235. |
All Office Actions, U.S. Appl. No. 15/446,450. |
PCT International Search Report, mailed Jun. 9, 2017 (12 pages). |
Print of page bearing heading “Marian Medical, Inc.,” and bearing date Aug. 11, 2013 (2 pages). |
Print of page bearing heading “Marian Medical, Inc.,” and bearing date Feb. 13, 2017 (2 pages). |
Website: bttp :/ /www.small-beginnings.com/# ! blank/ co pk, Phototherapy Diapers‘Beary Small’ Bili-Buns, 2015. |
All Office Actions; U.S. Appl. No. 17/555,993, filed on Dec. 20, 2021. |
U.S. Appl. No. 17/555,993, filed on Dec. 20, 2021, to Jacob Alan Barnhorst et al. |
Number | Date | Country | |
---|---|---|---|
20230063972 A1 | Mar 2023 | US |
Number | Date | Country | |
---|---|---|---|
62301679 | Mar 2016 | US | |
62315961 | Mar 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15446077 | Mar 2017 | US |
Child | 17463580 | US |